PSB
ALNY icon

Piscataqua Savings Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Piscataqua Savings Bank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Hold
50
– – 0.01% 315
2026
Q1 		$16.5K Hold
50
– – 0.01% 301
2025
Q4 		$19.9K Hold
50
– – 0.01% 277
2025
Q3 		$22.8K Hold
50
– – 0.02% 226
2025
Q2 		$16.3K Hold
50
– – 0.01% 253
2025
Q1 		$13.5K Hold
50
– – 0.01% 251
2024
Q4 		$11.8K Hold
50
– – 0.01% 260
2024
Q3 		$13.8K Buy
50
+35
+233% +$9.11K 0.01% 253
2024
Q2 		$3.65K Hold
15
– – ﹤0.01% 300
2024
Q1 		$2.24K Hold
15
– – ﹤0.01% 347
2023
Q4 		$2.87K Hold
15
– – ﹤0.01% 314
2023
Q3 		$2.66K Hold
15
– – ﹤0.01% 321
2023
Q2 		$2.85K Hold
15
– – ﹤0.01% 312
2023
Q1 		$3K Hold
15
– – ﹤0.01% 314
2022
Q4 		$3.56K Hold
15
– – ﹤0.01% 300
2022
Q3 		$3K Buy
+15
New +$2.86K ﹤0.01% 296

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Piscataqua Savings Bank's ALNY Position: Q2 2026 in Review

Piscataqua Savings Bank held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 50 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #315.

Piscataqua Savings Bank first reported a position in ALNY in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.8K in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Piscataqua Savings Bank held 50 shares of Alnylam Pharmaceuticals worth $15.1K as of Q2 2026.
  • Piscataqua Savings Bank left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #315 holding.
  • Piscataqua Savings Bank first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Piscataqua Savings Bank's Alnylam Pharmaceuticals position peaked at $22.8K in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.